Article
Strategies for robust, accurate, and generalizable benchmarking of drug discovery platforms
2024-12-16
Abstract excerpt
Benchmarking is essential for the improvement and comparison of drug discovery platforms. We revised the protocols used to benchmark our Computational Analysis of Novel Drug Opportunities (CANDO) multiscale therapeutic discovery platform to bring them into strong alignment with best practices.CANDO ranked 7.4% and 12.1% of known drugs in the top 10 compounds for their respective diseases/indications using drug-ind...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 165d3a48-f7e2-5e10-99bb-9220ef812a93
- DOI
- 10.1101/2024.12.10.627863
